Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1881)
All Articles published online
|
Mar 21, 2008 (publication date) through Feb 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Matsuda Y. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma. World J Gastroenterol 2008; 14(11): 1734-1740 [PMID: PMC2695913 DOI: 10.3748/wjg.14.1734] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i11/1734.htm |
| Number | Citing Articles |
| 1 |
Debolina Pal, Subhayan Sur, Suvra Mandal, Ashes Das, Anup Roy, Sukta Das, Chinmay Kumar Panda. Prevention of liver carcinogenesis by amarogentin through modulation of G 1 /S cell cycle check point and induction of apoptosis. Carcinogenesis 2012; 33(12): 2424 doi: 10.1093/carcin/bgs276
|
| 2 |
Masumeh Sanaei, Fraidoon Kavoosi. Effect of 5'-fluoro-2'-deoxycytidine, 5-azacytidine, and 5-aza-2'–deoxycytidine on DNA Methyltransferase 1, CIP/KIP Family, and INK4a/ARF in Colon Cancer HCT-116 Cell Line. International Journal of Cancer Management 2022; 14(12) doi: 10.5812/ijcm.110419
|
| 3 |
Jiaying Cai, Qichao Hu, Zhelin He, Xiaoyan Chen, Jian Wang, Xiang Yin, Xiao Ma, Jinhao Zeng. Scutellaria baicalensis Georgi and Their Natural Flavonoid Compounds in the Treatment of Ovarian Cancer: A Review. Molecules 2023; 28(13): 5082 doi: 10.3390/molecules28135082
|
| 4 |
Hitoshi Hino, Ping Dai, Tatsushi Yoshida, Tomoya Hatakeyama, Yoshinori Harada, Eigo Otsuji, Tsukasa Okuda, Tetsuro Takamatsu. Interaction of Cx43 with Hsc70 regulates G1/S transition through CDK inhibitor p27. Scientific Reports 2015; 5(1) doi: 10.1038/srep15365
|
| 5 |
Enyi Gao, Xiaoya Sun, Rick Francis Thorne, Xu Dong Zhang, Jinming Li, Fengmin Shao, Jianli Ma, Mian Wu. NIPSNAP1 directs dual mechanisms to restrain senescence in cancer cells. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04232-1
|
| 6 |
Zhi-yi Guo, Xiao-hui Hao, Fei-Fei Tan, Xin Pei, Li-Mei Shang, Xue-lian Jiang, Fang Yang. The elements of human cyclin D1 promoter and regulation involved. Clinical Epigenetics 2011; 2(2): 63 doi: 10.1007/s13148-010-0018-y
|
| 7 |
Arig Aly Seif, Heba Hassan Aly, Doaa Mostafa Elzoghby, Ashraf Mohammed Elbreedy, Mohamed Lotfy. Aberrant p16 methylation as an early diagnostic marker in blood of hepatocellular carcinoma patients. Egyptian Journal of Medical Human Genetics 2019; 20(1) doi: 10.1186/s43042-019-0027-0
|
| 8 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_174-1
|
| 9 |
Anne Catharina Dressler, Gernot Hudelist, Anneliese Fink-Retter, Daphne Gschwantler-Kaulich, Georg Pfeiler, Margit Rosner, Markus Hengstschläger, Christian F. Singer. Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations. Journal of Cancer Research and Clinical Oncology 2013; 139(8): 1349 doi: 10.1007/s00432-013-1443-z
|
| 10 |
Michael Sherman. Major heat shock protein Hsp72 controls oncogene‐induced senescence. Annals of the New York Academy of Sciences 2010; 1197(1): 152 doi: 10.1111/j.1749-6632.2010.05196.x
|
| 11 |
XU-ZHENG CHEN, ZHI-YUN CAO, TUAN-SHENG CHEN, YOU-QUAN ZHANG, ZHI-ZHEN LIU, YIN-TAO SU, LIAN-MING LIAO, JIAN DU. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway. Oncology Reports 2012; 28(2): 742 doi: 10.3892/or.2012.1834
|
| 12 |
Igor Malyshev. Immunity, Tumors and Aging: The Role of HSP70. SpringerBriefs in Biochemistry and Molecular Biology 2013; 6: 83 doi: 10.1007/978-94-007-5943-5_6
|
| 13 |
Kyoko Oura, Tomoko Tadokoro, Shintaro Fujihara, Asahiro Morishita, Taiga Chiyo, Eri Samukawa, Yoshimi Yamana, Koji Fujita, Teppei Sakamoto, Takako Nomura, Hirohito Yoneyama, Hideki Kobara, Hirohito Mori, Hisakazu Iwama, Keiichi Okano, Yasuyuki Suzuki, Tsutomu Masaki. Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest. Oncology Reports 2017; 38(5): 2825 doi: 10.3892/or.2017.5977
|
| 14 |
Mark J. Hoenerhoff, Arun R. Pandiri, Stephanie A. Lahousse, Hu-Hua Hong, Tai-Vu Ton, Tiwanda Masinde, Scott S. Auerbach, Kevin Gerrish, Pierre R. Bushel, Keith R. Shockley, Shyamal D. Peddada, Robert C. Sills. Global Gene Profiling of Spontaneous Hepatocellular Carcinoma in B6C3F1 Mice. Toxicologic Pathology 2011; 39(4): 678 doi: 10.1177/0192623311407213
|
| 15 |
Azza E El Bassiouny, Mona M Nosseir, Mona K Zoheiry, Noha A Ameen, Ahmed M Abdel-Hadi, Ibrahim M Ibrahim, Suher Zada, Abdel-Hakeem Saad El-Deen, Nora E El-Bassiouni. Differential expression of cell cycle regulators in HCV-infection and related hepatocellular carcinoma. World Journal of Hepatology 2010; 2(1): 32-41 doi: 10.4254/wjh.v2.i1.32
|
| 16 |
Ana Belén Cabrejas-Peñuelas. The Compensation Strategies of an Advanced and a Less Advanced Language Learner: A Case Study. Theory and Practice in Language Studies 2012; 2(7) doi: 10.4304/tpls.2.7.1341-1354
|
| 17 |
Eri Samukawa, Shintaro Fujihara, Kyoko Oura, Hisakazu Iwama, Yoshimi Yamana, Tomoko Tadokoro, Taiga Chiyo, Kiyoyuki Kobayashi, Asahiro Morishita, Mai Nakahara, Hideki Kobara, Hirohito Mori, Keiichi Okano, Yasuyuki Suzuki, Takashi Himoto, Tsutomu Masaki. Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest. International Journal of Oncology 2017; 51(6): 1674 doi: 10.3892/ijo.2017.4177
|
| 18 |
Yoshimi Yamana, Shintaro Fujihara, Hideki Kobara, Kyoko Oura, Eri Samukawa, Taiga Chiyo, Megumi Okamura, Hiroki Yamana, Tomoko Tadokoro, Koji Fujita, Asahiro Morishita, Hisakazu Iwama, Tsutomu Masaki. MicroRNA profiles following telmisartan treatment in pancreatic ductal adenocarcinoma cells. Journal of Cancer Research and Therapeutics 2022; 18(Suppl 2): S305 doi: 10.4103/jcrt.JCRT_104_20
|
| 19 |
Rosa M. Pascale, Maria M. Simile, Graziella Peitta, Maria A. Seddaiu, Francesco Feo, Diego F. Calvisi. Experimental Models to Define the Genetic Predisposition to Liver Cancer. Cancers 2019; 11(10): 1450 doi: 10.3390/cancers11101450
|
| 20 |
Diego F. Calvisi, Maddalena Frau, Maria L. Tomasi, Francesco Feo, Rosa M. Pascale. Deregulation of signalling pathways in prognostic subtypes of hepatocellular carcinoma: Novel insights from interspecies comparison. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012; 1826(1): 215 doi: 10.1016/j.bbcan.2012.04.003
|
| 21 |
Giuseppe Castello, Stefania Scala, Giuseppe Palmieri, Steven A. Curley, Francesco Izzo. HCV-related hepatocellular carcinoma: From chronic inflammation to cancer. Clinical Immunology 2010; 134(3): 237 doi: 10.1016/j.clim.2009.10.007
|
| 22 |
Patrizia Bonelli, Franca Maria Tuccillo, Antonella Borrelli, Antonietta Schiattarella, Franco Maria Buonaguro. CDK/CCN and CDKI Alterations for Cancer Prognosis and Therapeutic Predictivity. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/361020
|
| 23 |
Jin-Hee Seo, Eui-Suk Jeong, Yang-Kyu Choi. Therapeutic effects of lentivirus-mediated shRNA targeting of cyclin D1 in human gastric cancer. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-175
|
| 24 |
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival. World Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
|
| 25 |
Jérémy Huard, Stephanie Mueller, Ernst D. Gilles, Ursula Klingmüller, Steffen Klamt. An integrative model links multiple inputs and signaling pathways to the onset of DNA synthesis in hepatocytes. The FEBS Journal 2012; 279(18): 3290 doi: 10.1111/j.1742-4658.2012.08572.x
|
| 26 |
Peng Gao, Zhanwei Wang, Bin Zhang, Yourui Zou, Hui Guo, Haibo Liu, Qiang Yang, Zhihao Fang, Shucai Jiang, Bing Shen, Louis W.C. Chow, Wings Tjing-yung Loo, Elizabeth L.Y. Ng, William W.N. Tsang. Suppression of C6 Gliomas via Application of Rat Hyperplasia Gene. The International Journal of Biological Markers 2014; 29(4): 411 doi: 10.5301/jbm.5000114
|
| 27 |
Yasunobu Matsuda, Toshifumi Wakai, Masayuki Kubota, Masaaki Takamura, Satoshi Yamagiwa, Yutaka Aoyagi, Mami Osawa, Shun Fujimaki, Ayumi Sanpei, Takuya Genda, Takafumi Ichida. Clinical significance of cell cycle inhibitors in hepatocellular carcinoma. Medical Molecular Morphology 2013; 46(4): 185 doi: 10.1007/s00795-013-0047-7
|
| 28 |
Arun J. Sanyal, Seung Kew Yoon, Riccardo Lencioni. The Etiology of Hepatocellular Carcinoma and Consequences for Treatment. The Oncologist 2010; 15(S4): 14 doi: 10.1634/theoncologist.2010-S4-14
|
| 29 |
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fiction. World Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
|
| 30 |
Diego F. Calvisi, Sara Ladu, Federico Pinna, Maddalena Frau, Maria L. Tomasi, Marcella Sini, Maria M. Simile, Piero Bonelli, Maria R. Muroni, Maria A. Seddaiu, Dae–Sik Lim, Francesco Feo, Rosa M. Pascale. SKP2 and CKS1 Promote Degradation of Cell Cycle Regulators and Are Associated With Hepatocellular Carcinoma Prognosis. Gastroenterology 2009; 137(5): 1816 doi: 10.1053/j.gastro.2009.08.005
|
| 31 |
C Wan, S Hou, R Ni, L Lv, Z Ding, X Huang, Q Hang, S He, Y Wang, C Cheng, X X Gu, G Xu, A Shen. MIF4G domain containing protein regulates cell cycle and hepatic carcinogenesis by antagonizing CDK2-dependent p27 stability. Oncogene 2015; 34(2): 237 doi: 10.1038/onc.2013.536
|
| 32 |
A. Kathleen McClendon, Jeffry L. Dean, Adam Ertel, Zhiyan Fu, Dayana B. Rivadeneira, Christopher A. Reed, Ryan J. Bourgo, Agnieszka Witkiewicz, Sankar Addya, Christopher N. Mayhew, H. Leighton Grimes, Paolo Fortina, Erik S. Knudsen. RB and p53 Cooperate to Prevent Liver Tumorigenesis in Response to Tissue Damage. Gastroenterology 2011; 141(4): 1439 doi: 10.1053/j.gastro.2011.06.046
|
| 33 |
Hongyang Wang, Yaqin He, Wen Yang. Primary Liver Cancer. 2012; : 179 doi: 10.1007/978-3-642-28702-2_6
|
| 34 |
Nuray Bassullu, Ilknur Turkmen, Murat Dayangac, Pinar Yagiz Korkmaz, Reyhan Yasar, Murat Akyildiz, Onur Yaprak, Yaman Tokat, Yildiray Yuzer, Gulen Bulbul Dogusoy. The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma. Hepatitis Monthly 2012; 12(10) doi: 10.5812/hepatmon.7492
|
| 35 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3173 doi: 10.1007/978-3-319-26956-6_174
|
| 36 |
Ganganapalli Supraja, Kalisetty Chengaiahgari Maheswari, Deepika Pamarthy, Kallimakula Venkata Reddy Saritha. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022; : 109 doi: 10.1016/B978-0-323-99283-1.00006-9
|
| 37 |
Maria A. Livrea, Luisa Tesoriere. Pigments in Fruits and Vegetables. 2015; : 141 doi: 10.1007/978-1-4939-2356-4_7
|
| 38 |
Shen Shen, Dylan C. Dean, Zujiang Yu, Zhenfeng Duan. Role of cyclin‐dependent kinases (CDKs) in hepatocellular carcinoma: Therapeutic potential of targeting the CDK signaling pathway. Hepatology Research 2019; 49(10): 1097 doi: 10.1111/hepr.13353
|
| 39 |
Yasunobu Matsuda, Toshifumi Wakai, Yuki Hirose, Mami Osawa, Shun Fujimaki, Masayuki Kubota. p27 Is a Critical Prognostic Biomarker in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma. International Journal of Molecular Sciences 2013; 14(12): 23499 doi: 10.3390/ijms141223499
|
| 40 |
Fangqiao Lv, Jun Wu, Dengshun Miao, Wei An, Yutong Wang. p16 deficiency promotes nonalcoholic steatohepatitis via regulation of hepatic oxidative stress. Biochemical and Biophysical Research Communications 2017; 486(2): 264 doi: 10.1016/j.bbrc.2017.03.023
|
| 41 |
EBRU ESIN YORUKER, UFUK MERT, DURSUN BUGRA, SUMER YAMANER, NEJAT DALAY. Promoter and histone methylation and p16INK4A gene expression in colon cancer. Experimental and Therapeutic Medicine 2012; 4(5): 865 doi: 10.3892/etm.2012.683
|
| 42 |
Ghada Hosny, Omar A Ahmed, Rania Makboul Ahmed, Sabah Ahmed Fadel. Expression of p16 Tumor Suppressor Protein in Malignant Ovarian Germ Cell Tumors; Immunohistochemical Study. International Journal of Surgical Pathology 2024; 32(1): 66 doi: 10.1177/10668969231168358
|
| 43 |
Solange S. Lewis, Gregory J. Weber, Jennifer L. Freeman, Maria S. Sepúlveda. Toxicology and Epigenetics. 2012; : 73 doi: 10.1002/9781118349045.ch5
|
| 44 |
Dan Sun, Lu Han, Rui Cao, Huali Wang, Jiyong Jiang, Yanjie Deng, Xiaohui Yu. Prediction of a miRNA‐mRNA functional synergistic network for cervical squamous cell carcinoma. FEBS Open Bio 2019; 9(12): 2080 doi: 10.1002/2211-5463.12747
|
| 45 |
Phytochemical profiling, antioxidant and antiproliferation potential of Euphorbia milii var.: Experimental analysis and in-silico validation. Saudi Journal of Biological Sciences 2020; 27(11): 3025 doi: 10.1016/j.sjbs.2020.08.003
|
| 46 |
Hani Alotaibi, Nese Atabey, Kasım Diril, Esra Erdal, Mehmet Ozturk. Hepatocellular Carcinoma. 2016; : 43 doi: 10.1007/978-3-319-34214-6_3
|
| 47 |
Kelly Lauter, Andrew Arnold. Handbook of Parathyroid Diseases. 2012; : 257 doi: 10.1007/978-1-4614-2164-1_16
|
| 48 |
Kenji Yorita, Akinobu Ohno, Hiroaki Kataoka. Emerging histopathological prognostic biomarkers in hepatocellular carcinomas. Personalized Medicine Universe 2014; 3: 15 doi: 10.1016/j.pmu.2014.03.006
|
| 49 |
James P Hamilton. Epigenetic Mechanisms Involved in the Pathogenesis of Hepatobiliary Malignancies. Epigenomics 2010; 2(2): 233 doi: 10.2217/epi.10.9
|
| 50 |
Eugenia M. Clerico, Lila M. Gierasch. Inhibitors of Molecular Chaperones as Therapeutic Agents. 2013; : 65 doi: 10.1039/9781849739689-00065
|
| 51 |
Ashish Singhal, Muralidharan Jayaraman, Danny N. Dhanasekaran, Vivek Kohli. Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence. Critical Reviews in Oncology/Hematology 2012; 82(2): 116 doi: 10.1016/j.critrevonc.2011.05.005
|
| 52 |
Cornelia Tolg, Nesrin Sabha, Rene Cortese, Trupti Panchal, Alya Ahsan, Ashraf Soliman, Karen J Aitken, Arturas Petronis, Darius J Bägli. Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. Laboratory Investigation 2011; 91(6): 825 doi: 10.1038/labinvest.2010.197
|
| 53 |
Oranous Bashti Shiraz, Hamid Galehdari, Majid Yavarian, Bita Geramizadeh. Possible Down Regulation of the p16 Gene Promoter in Individuals with Hepatocellular Carcinoma. Hepatitis Monthly 2011; 11(9): 719 doi: 10.5812/kowsar.1735143X.588
|